Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| IOT | Phillips Dominic | SEE REMARKS | 08/03/2026 | Verkauf | 38.40 | 600 | 23,038 | Form 4 |
| IOT | Phillips Dominic | SEE REMARKS | 08/03/2026 | Verkauf | 37.58 | 11,110 | 417,550 | Form 4 |
| SPFI | Campbell Richard D | Director | 08/03/2026 | Verkauf | 44.75 | 132,714 | 5,938,952 | Form 4 |
| SKYW | Steel Wade J | CHIEF COMMERCIAL OFFICER | 08/03/2026 | Verkauf | 111.44 | 22,000 | 2,451,676 | Form 4 |
| SIBN | Dunn Jeffrey W | Director | 08/03/2026 | Verkauf | 18.46 | 20,000 | 369,214 | Form 4 |
| SI | Gilde Healthcare Holding B.V. | 10% Owner | 08/03/2026 | Verkauf | 22.71 | 10,751 | 244,155 | Form 4 |
| SMG | Hagedorn Partnership, L.P. | Director | 08/03/2026 | Verkauf | 68.16 | 1,207 | 82,271 | Form 4 |
| SMG | Hagedorn Partnership, L.P. | Director | 08/03/2026 | Verkauf | 67.42 | 28,793 | 1,941,322 | Form 4 |
| RSI | Stetz Mattias | Chief Operating Officer | 08/03/2026 | Verkauf | 28.03 | 20,000 | 560,556 | Form 4 |
| RSI | Schwartz Richard Todd | Chief Executive Officer | 08/03/2026 | Verkauf | 28.02 | 55,556 | 1,556,890 | Form 4 |
| RSI | Schwartz Richard Todd | Chief Executive Officer | 08/03/2026 | Verkauf | 28.02 | 47,222 | 1,323,250 | Form 4 |
| RSI | Sauers Kyle | Chief Financial Officer | 08/03/2026 | Verkauf | 26.65 | 23,000 | 612,950 | Form 4 |
| RBRK | Nithrakashyap Arvind | Chief Technology Officer | 08/03/2026 | Verkauf | 74.52 | 5,178 | 385,865 | Form 4 |
| RBRK | Nithrakashyap Arvind | Chief Technology Officer | 08/03/2026 | Verkauf | 73.72 | 7,642 | 563,368 | Form 4 |
| HOOD | Robinhood Markets, Inc. | 10% Owner | 08/03/2026 | Verkauf | 28.22 | 2,341 | 66,063 | Form 4 |
| HOOD | Robinhood Markets, Inc. | 10% Owner | 08/03/2026 | Verkauf | 27.53 | 12,647 | 348,172 | Form 4 |
| HOOD | Robinhood Markets, Inc. | 10% Owner | 08/03/2026 | Verkauf | 26.52 | 5,754 | 152,596 | Form 4 |
| HOOD | Robinhood Markets, Inc. | 10% Owner | 08/03/2026 | Verkauf | 25.53 | 6,398 | 163,341 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 91.80 | 2,900 | 266,232 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 90.94 | 3,400 | 309,201 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 90.06 | 2,200 | 198,134 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 89.08 | 300 | 26,723 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 87.20 | 400 | 34,878 | Form 4 |
| HOOD | Gallagher Daniel Martin Jr | Chief Legal Officer | 08/03/2026 | Verkauf | 86.28 | 800 | 69,023 | Form 4 |
| RUSHB | McRoberts Michael | Director | 08/03/2026 | Verkauf | 81.44 | 6,500 | 529,328 | Form 4 |
| ROKU | Banks Matthew C. | VP, CAO | 08/03/2026 | Verkauf | 146.25 | 552 | 80,730 | Form 4 |
| ROKU | Hunt Neil D | Director | 08/03/2026 | Verkauf | 146.98 | 112 | 16,462 | Form 4 |
| ROKU | Hunt Neil D | Director | 08/03/2026 | Verkauf | 146.21 | 1,888 | 276,044 | Form 4 |
| RELL | Halverson Kenneth | Director | 08/03/2026 | Verkauf | 18.77 | 5,000 | 93,854 | Form 4 |
| RELL | Benham James | Director | 08/03/2026 | Verkauf | 18.50 | 9,836 | 181,966 | Form 4 |
| QMCO | Craythorne Anthony | Chief Revenue Officer | 08/03/2026 | Verkauf | 10.73 | 1,478 | 15,856 | Form 4 |
| PCOR | O Connor Kevin J | Director | 08/03/2026 | Verkauf | 55.84 | 3,932 | 219,563 | Form 4 |
| PCOR | O Connor Kevin J | Director | 08/03/2026 | Verkauf | 55.05 | 8,167 | 449,593 | Form 4 |
| PCOR | O Connor Kevin J | Director | 08/03/2026 | Verkauf | 53.52 | 3,287 | 175,920 | Form 4 |
| CNXN | Mcgrath Timothy J | President & CEO | 08/03/2026 | Verkauf | 86.23 | 12,630 | 1,089,085 | Form 4 |
| CNXN | Mcgrath Timothy J | President & CEO | 08/03/2026 | Verkauf | 85.49 | 22,049 | 1,884,969 | Form 4 |
| CNXN | Mcgrath Timothy J | President & CEO | 08/03/2026 | Verkauf | 84.17 | 1,000 | 84,170 | Form 4 |
| PBF | Fedena James E. | Senior Vice President | 08/03/2026 | Verkauf | 71.83 | 24,756 | 1,778,181 | Form 4 |
| PKG | Hassfurther Thomas A | President | 08/03/2026 | Verkauf | 250.00 | 12,531 | 3,132,750 | Form 4 |
| OPTU | Olsen Michael | General Counsel and CCRO | 08/03/2026 | Verkauf | 0.74 | 20,000 | 14,800 | Form 4 |
| OMDA | Duffy Sean P. | Chief Executive Officer | 08/03/2026 | Verkauf | 20.40 | 12,944 | 264,007 | Form 4 |
| OKLO | Cochran Caroline | Co-Founder, COO | 08/03/2026 | Verkauf | 40.94 | 7,151 | 292,762 | Form 4 |
| OKLO | Cochran Caroline | Co-Founder, COO | 08/03/2026 | Verkauf | 40.14 | 12,849 | 515,759 | Form 4 |
| OKLO | Cochran Caroline | Co-Founder, COO | 08/03/2026 | Verkauf | 39.60 | 3,500 | 138,600 | Form 4 |
| OKLO | Cochran Caroline | Co-Founder, COO | 08/03/2026 | Verkauf | 38.55 | 16,500 | 636,075 | Form 4 |
| OKLO | Cochran Caroline | Co-Founder, COO | 08/03/2026 | Verkauf | 41.68 | 40,000 | 1,667,200 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 39.60 | 3,500 | 138,600 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 38.55 | 16,500 | 636,075 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 40.94 | 7,151 | 292,762 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 40.14 | 12,849 | 515,759 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 41.35 | 40,000 | 1,654,000 | Form 4 |
| OKLO | Bealmear Richard Craig | Chief Financial Officer | 08/03/2026 | Verkauf | 38.80 | 16,452 | 638,338 | Form 4 |
| NTRA | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 08/03/2026 | Verkauf | 267.99 | 295 | 79,057 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 268.70 | 128 | 34,393 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 267.79 | 1,233 | 330,181 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 265.28 | 192 | 50,933 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 263.94 | 947 | 249,953 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 261.49 | 200 | 52,298 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 259.98 | 300 | 77,994 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 267.99 | 410 | 109,876 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).